U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07846891) titled 'Low Level Laser Therapy With Injectable Platelet Rich Fibrin in Management of Oral Lichen Planus' on Sept. 23.
Brief Summary: The Injectable PRF (i-PRF) is a variant of PRF, which is a liquid blood derivative rich in leukocytes and acts as a growth factor release, with its potential anti-inflammatory role, it may alleviate the symptoms of OLP.
Low Level Laser Therapy (LLLT) emits short wavelength red or infrared light between (500-1100 nm) with a low water absorption. This light can reach a depth of 3 mm to 15 mm in both soft and hard tissues, the biostimulatory effect of laser irradiation results in physiological, metabolic, and ...